Therapeutic management and Haemato-biochemical changes of Babesiosis in dogs
Praveen Kumar and Abhishek Kumar
This study was done to investigate the therapeutic efficacy of imidocarb dipropionate against babesiosis in dogs. A total of eighteen dogs diagnosed positive for babesiosis were taken for study which were presented at Department of Veterinary Medicine, Ranchi Veterinary College, Kanke, Ranchi, Jharkhand, India. They were diagnosed on history of ticks’ infestation, characteristic clinical features and hematological examinations. These 18 dogs were divided randomly into 3 groups having 6 dogs in each. Group 1 was treated with Imidocarb @ 6 mg/kg; S/C, whereas Group 2 with Oxytetracycline & Doxycycline @ 10mg/kg; I/V & 6.6 mg/kg; PO, respectively and Group 3 with Diminazine @ 0.1 ml/2kg; I/M. Group 1 showed 100% recovery on 3rd day, while Group 2 & 3 showed 66.6%, recovery on 10th day and 7th day, respectively on blood smear examination for babesiosis. Since, the use of Imidocarb dipropionate has a number of advantages over that of Doxycycline, Oxytetracycline and Diminazine, comparative hematological tests were carried out to more definitively determine the efficacy of Imidocarb dipropionate in canine babesia. All the hemato-biochemical values came to normalcy at the treatment of 10th day in gr 1 whereas in group 2 & 3 normal parameters were observed on 14th day.